Masao Hagihara
Overview
Explore the profile of Masao Hagihara including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
101
Citations
791
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nakano H, Nakashima S, Imai Y, Uchida T, Inoue M, Hagihara M
Rinsho Ketsueki
. 2025 Feb;
66(1):3-6.
PMID: 39924204
We retrospectively analyzed the efficacy of tixagevimab/cilgavimab (Tix/Cil) in 142 patients (total of 157 injections) with hematological disorders. Fifteen patients (9.5%) were infected with coronavirus disease (COVID-19), and 3 of...
2.
Hagihara M, Yasu T, Gando Y, Sugi T, Nakashima S, Imai Y, et al.
Ann Hematol
. 2024 Sep;
103(11):4497-4502.
PMID: 39327313
The administration of venetoclax (Ven) with azacitidine (Aza) was used as induction or salvage therapy for 34 patients with acute myeloid leukemia (AML) in our institute. An itraconazole oral solution...
3.
Nakashima S, Ohara S, Imai Y, Nakano H, Uchida T, Inoue M, et al.
Rinsho Ketsueki
. 2024 Mar;
65(2):74-77.
PMID: 38448001
An 80-year-old Japanese man presented with systemic lymphadenopathy, including the para-aortic area and left inguinal nodes, which was diagnosed as diffuse large B-cell lymphoma (DLBCL) and human herpesvirus (HHV) 8-positive/HIV-negative...
4.
Yamayoshi S, Nagai E, Mitamura K, Hagihara M, Kobayashi R, Takahashi S, et al.
Epidemiol Infect
. 2024 Jan;
152:e24.
PMID: 38258464
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) emerged in 2019 in China and rapidly spread worldwide, leading to a pandemic. The threat of SARS-CoV-2 is subsiding as most people have...
5.
Hagihara M, Hayashi H, Nakashima S, Imai Y, Nakano H, Uchida T, et al.
Intern Med
. 2024 Jan;
63(16):2283-2287.
PMID: 38171874
Objective Prolonged severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been reported in immunocompromised patients, as they poorly develop antibodies against SARS-CoV-2. We conducted a clinical trial to determine...
6.
Shide K, Takenaka K, Kitanaka A, Numata A, Kameda T, Yamauchi T, et al.
Ann Hematol
. 2023 Nov;
103(1):97-103.
PMID: 37946031
There are few prospective studies on patients with post-essential thrombocythemia myelofibrosis (PET-MF) and post-polycythemia vera myelofibrosis (PPV-MF). Therefore, we conducted a nationwide longitudinal prospective survey to clarify the clinical characteristics...
7.
Sugi T, Mita M, Kushi R, Hanai H, Uchida T, Inoue M, et al.
Int J Clin Pharmacol Ther
. 2023 Aug;
61(11):515-519.
PMID: 37622674
Objective: At our institution, patients with hematological disease who require pneumonia (PJP) prophylaxis were administered atovaquone at a low dose (750 mg/day). However, there have been few reports on the...
8.
Shide K, Takenaka K, Kitanaka A, Numata A, Kameda T, Yamauchi T, et al.
Blood Cancer J
. 2023 Jul;
13(1):110.
PMID: 37463903
No abstract available.
9.
Hagihara M, Sugi T, Hayashi H, Nakashima S, Ohara S, Imai Y, et al.
Rinsho Ketsueki
. 2023 Mar;
64(2):133-136.
PMID: 36990734
In our facility, anti-SARS-CoV-2 mRNA vaccines were given to 21 patients, including 8 with aplastic anemia (AA), 3 with pure red cell aplasia (PRCA), and 10 with immune thrombocytopenic purpura...
10.
Suyama T, Hagihara M, Matsui N, Irie R, Osamura Y, Sakai T, et al.
J Clin Exp Hematop
. 2023 Feb;
63(1):43-48.
PMID: 36843069
We present the case of an 85-year-old male patient diagnosed with human herpesvirus 8 (HHV8)-negative effusion-based lymphoma (EBL) that developed from long-lasting pleural effusion (PE) induced by dasatinib treatment for...